Álmath is a qualified pharmacist and barrister-at-law with a PhD from Trinity College Dublin. Over the course of two decades, Álmath acquired a mix of public and private sector experience. Prior to joinng industry, Dr. Spooner held leadership roles at the Irish Health Authority (HPRA), and at European Medicines Agency (EMA) as the first Vice Chair of the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) where she  served for the maximum of two terms (2012-2018).

Álmath was called to the Bar of Ireland in 2018 and practiced as a Barrister prior to joining AbbVie's Global Regulatory Policy and Intelligence team in 2020. Álmath leads the European region for Regulatory Policy at AbbVie and is the global policy topic lead for Real World Evidence and Patient Focused Drug Development. Álmath chairs EFPIA’s expert working on Integrated Evidence Generation and Use and co-chairs a subgroup on Patient Engagement. She is also a member of EFPIA’s Innovation Board Sponsored Committee and Regulatory Strategy Committee. Álmath has participated in various international initiatives including ICH, ICMRA, ISPE and CIOMS and has represented the EU in ICH EWGs.